Comparison of Deferasirox and Desferoxamine in Patients of β-Thalassemia Major With Iron Overload

NCT06468423 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

142

Enrollment

OTHER

Sponsor class

Conditions

Pateints of β-thalassemia Major With Iron Overload

Interventions

DRUG: Deferasirox (DFX)
DRUG: Deferoxamine (DFO)

Sponsor

RESnTEC, Institute of Research